0.3489
price down icon1.44%   -0.0051
after-market After Hours: .34 -0.0089 -2.55%
loading

Organovo Holdings Inc Stock (ONVO) Latest News

pulisher
02:15 AM

Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World

02:15 AM
pulisher
02:09 AM

Organ On Chip Market Growing Rapidly: Emulate Inc., Mimetas B.V., Insphero, Organovo Holdings - openPR

02:09 AM
pulisher
Jan 28, 2025

Next Generation Bioprinting Market Top Companies StudyEOS - openPR

Jan 28, 2025
pulisher
Jan 27, 2025

3D Bioprinting Market: Future Scope, Growth Potential, - openPR

Jan 27, 2025
pulisher
Jan 22, 2025

Organovo faces potential Nasdaq delisting - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

3D Bioprinting Technology Market to Witness Stunning Growth | - openPR

Jan 22, 2025
pulisher
Jan 17, 2025

3D Bioprinting in Medical Market Worth $4.9 billion by 2032 | - openPR

Jan 17, 2025
pulisher
Jan 14, 2025

Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World

Jan 14, 2025
pulisher
Jan 06, 2025

Organovo names new CFO amid clinical advancements By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Appoints Norman Staskey as Chief Financial Officer - citybiz

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo names new CFO amid clinical advancements - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Appoints M&A Veteran CFO as FXR314 Drug Shows Promising Phase 2 Results - StockTitan

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo (NASDAQ:ONVO) Coverage Initiated at StockNews.com - Defense World

Jan 06, 2025
pulisher
Dec 31, 2024

Organovo appoints new president and CFO amid strategic plans By Investing.com - Investing.com Nigeria

Dec 31, 2024
pulisher
Dec 31, 2024

Organovo appoints new president and CFO amid strategic plans - Investing.com India

Dec 31, 2024
pulisher
Dec 31, 2024

Organovo Holdings Appoints Norman Staskey as New CFO - TipRanks

Dec 31, 2024
pulisher
Dec 22, 2024

Analyzing Sorrento Therapeutics (OTCMKTS:SRNEQ) and Organovo (NASDAQ:ONVO) - Defense World

Dec 22, 2024
pulisher
Dec 18, 2024

Top 10 4D Printing Companies | Provides Best TechMarket.us Scoop - Market.us Scoop - Market News

Dec 18, 2024
pulisher
Dec 18, 2024

Healthcare 4D Printing Market Top Companies Study3D Systems - openPR

Dec 18, 2024
pulisher
Dec 17, 2024

3D Print Organ Market 2024 to Witness Huge Growth by 2032 Prominent Players are Organovo Holdings, EnvisionTEC - openPR

Dec 17, 2024
pulisher
Dec 16, 2024

3D Bioprinting for Tissue and Organ Regeneration Market Top - openPR

Dec 16, 2024
pulisher
Dec 12, 2024

3D Bioprinting Equipment Sales Market Overview, Future Trends - openPR

Dec 12, 2024
pulisher
Dec 09, 2024

3D-Printed Organs Market is experiencing new opportunities & competitive edge highlighted by Top Market Key Players (Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc.) | Forecast to 2030 - Industry Today

Dec 09, 2024
pulisher
Dec 06, 2024

Empowering Growth: Bioprinting Services Market 2024 - openPR

Dec 06, 2024
pulisher
Dec 04, 2024

3D Bioprinting Market is Forecast to Achieve USD 2.0 Billion - openPR

Dec 04, 2024
pulisher
Dec 01, 2024

ONVO (Organovo Holdings) Enterprise Value : $5.31 Mil (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 23, 2024

Organovo expands equity incentive plan following stockholder approval By Investing.com - Investing.com Nigeria

Nov 23, 2024
pulisher
Nov 22, 2024

Organovo expands equity incentive plan following stockholder approval - Investing.com

Nov 22, 2024
pulisher
Nov 22, 2024

Organovo Holdings Gains Approval for Key Strategic Moves - TipRanks

Nov 22, 2024
pulisher
Nov 21, 2024

Industrial 3D Printing Market Size Analysis and Top Companies - Precedence Research

Nov 21, 2024
pulisher
Nov 21, 2024

ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com Australia

Nov 21, 2024
pulisher
Nov 20, 2024

Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Organovo's FXR314 Shows Significant Liver Fat Reduction in Phase 2 MASH Trial | ONVO Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

Human Liver Models Market 2024-2031| Emerging Technologies, - openPR

Nov 18, 2024
pulisher
Nov 15, 2024

Organovo stock plunges to 52-week low of $0.35 amid market challenges - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

3D Bioprinting Market Projected to Reach $$$ Billion by 2031 with - openPR

Nov 15, 2024
pulisher
Nov 15, 2024

Armistice Capital, LLC Increases Stake in Organovo Holdings Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - GlobeNewswire Inc.

Nov 14, 2024
pulisher
Nov 13, 2024

Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Organovo's FXR314 Drug Trial Data Selected for Major Liver Conference Presentation | ONVO Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

3D Printer Market to Grow by USD 30 Billion (2024-2028), Driven by Rising Consumer Demand for Customized Products, AI-Powered Report Highlights Market TransformationTechnavio - The Malaysian Reserve

Nov 12, 2024
pulisher
Nov 09, 2024

Is Health Care's Hottest Stock a Mirage? - AOL

Nov 09, 2024
pulisher
Nov 08, 2024

Organovo: Fiscal Q2 Earnings Snapshot - San Antonio Express-News

Nov 08, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):